1-2 of 2
Sripada V.S.S Prasad
Close
Sort by
Journal Articles

Final Results From a Phase II Trial with the First in Class Recombinant Polyclonal Antibody Product Rozrolimupab in Primary Immune Thrombocytopenia

Tadeusz Robak, Jacek Trelinski, Mario von Depka Prondzinski, Aristoteles Giagounidis, Chantal Doyen, MD, Ann Janssens, Mayte Álvarez Román, MD, Javier Loscertales Pueyo, Isidro Jarque Ramos, Javier Loscertales, Gloria Pérez Rus, Andrzej Hellmann, MD, Wieslaw Wiktor-Jedrzejczak, MD, PhD, Kazimierz Kuliczkowski, Lana Golubovic, Dusica Celeketic, Andrei Cucuianu, Emanuil Gheorghita, Lazaroiu Mihaela, Dina Attias, Ofer Shpilberg, MD, MPH, Elena Karyagina, Kateryna Vilchevska, Kalinina Svetlana, Nichola Cooper, MA MD MRCP FRCPath, Kate Talks, Mukyaprana Prabhu, Sripada V.S.S Prasad, T. P. Raghava Bharadwaj, Mimi Folden Flensburg, Jorgen Petersen, MD, PhD, Jerzy Windyga
Journal: Blood
Blood (2011) 118 (21): 527.
https://doi.org/10.1182/blood.V118.21.527.527
Published: 2011
Journal Articles

A Phase 1 Trial of Fluphenazine HCl (Fz), a Serotonin Antagonist, in Relapsed and Refractory Multiple Myeloma

Edward A. Stadtmauer, MD, David Siegel, MD, PhD, Dan T Vogl, MD, MS, James Stinnett, MD, Geetha Narayanan, MD, P.P. Bapsy, MD, Trivadi Ganesan, MBBS, MD, MNAMS, FRCP, MA, PhD, Minish Jain, MD, Sripada V.S.S Prasad, MD, DMs, Douglas S McNair, MD, PhD, Linda DeYoung, PhD, Alice Lane, Bruce Silver, MD
Journal: Blood
Blood (2008) 112 (11): 5188.
https://doi.org/10.1182/blood.V112.11.5188.5188
Published: 2008